ES557057A0 - Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico - Google Patents

Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico

Info

Publication number
ES557057A0
ES557057A0 ES557057A ES557057A ES557057A0 ES 557057 A0 ES557057 A0 ES 557057A0 ES 557057 A ES557057 A ES 557057A ES 557057 A ES557057 A ES 557057A ES 557057 A0 ES557057 A0 ES 557057A0
Authority
ES
Spain
Prior art keywords
amino
oxoethyliden
sulfooxi
tiazolil
dimetil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557057A
Other languages
English (en)
Other versions
ES8801917A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES557057A0 publication Critical patent/ES557057A0/es
Publication of ES8801917A1 publication Critical patent/ES8801917A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES557057A 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico Expired ES8801917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/695,775 US4638061A (en) 1985-01-28 1985-01-28 [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Publications (2)

Publication Number Publication Date
ES557057A0 true ES557057A0 (es) 1988-03-01
ES8801917A1 ES8801917A1 (es) 1988-03-01

Family

ID=24794413

Family Applications (3)

Application Number Title Priority Date Filing Date
ES551252A Expired ES8706112A1 (es) 1985-01-28 1986-01-27 Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ES557056A Expired ES8800897A1 (es) 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto 3(s)-3-amino-2-oxo-4,4-dimetil-1-azetidinilsulfato
ES557057A Expired ES8801917A1 (es) 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES551252A Expired ES8706112A1 (es) 1985-01-28 1986-01-27 Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ES557056A Expired ES8800897A1 (es) 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto 3(s)-3-amino-2-oxo-4,4-dimetil-1-azetidinilsulfato

Country Status (35)

Country Link
US (1) US4638061A (es)
JP (2) JPH0780840B2 (es)
KR (1) KR900000675B1 (es)
CN (1) CN1014894B (es)
AR (1) AR242024A1 (es)
AT (1) AT389511B (es)
AU (1) AU588017B2 (es)
BE (1) BE904121A (es)
CA (2) CA1283924C (es)
CH (3) CH670825A5 (es)
CS (1) CS253740B2 (es)
DD (3) DD241600A5 (es)
DE (1) DE3602347A1 (es)
DK (1) DK39486A (es)
EG (1) EG17682A (es)
ES (3) ES8706112A1 (es)
FI (1) FI85022C (es)
FR (1) FR2576596B1 (es)
GB (2) GB2170201B (es)
GR (1) GR860239B (es)
HU (1) HU196367B (es)
IE (2) IE930750L (es)
IL (1) IL77661A (es)
IT (1) IT1190604B (es)
LU (1) LU86262A1 (es)
NL (1) NL8600136A (es)
NO (1) NO170014C (es)
NZ (1) NZ214836A (es)
PH (3) PH22425A (es)
PL (3) PL257668A1 (es)
PT (1) PT81914B (es)
RO (1) RO93483B (es)
SE (3) SE467824B (es)
YU (2) YU45760B (es)
ZA (1) ZA86302B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751220A (en) * 1986-12-19 1988-06-14 E. R. Squibb & Sons, Inc. Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
EP0336667A3 (en) * 1988-04-04 1991-04-10 E.R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
US4973747A (en) * 1989-08-15 1990-11-27 E. R. Squibb & Sons, Inc. Process for preparing 3-hydroxy 2-keto acids
EP2308874B1 (en) * 2005-12-07 2013-01-23 Basilea Pharmaceutica AG Bridged monobactams useful as beta-lactamase inhibitors
WO2017180794A1 (en) 2016-04-13 2017-10-19 Skyline Antiinfectives, Inc. Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) * 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規2−アゼチジノン誘導体
JPS58206589A (ja) * 1982-05-26 1983-12-01 Yamanouchi Pharmaceut Co Ltd 2−アゼチジノン誘導体
US4565654A (en) * 1983-03-28 1986-01-21 University Of Notre Dame Du Lac N-Acyloxy monocyclic β-lactams

Also Published As

Publication number Publication date
AT389511B (de) 1989-12-27
PL262318A1 (en) 1987-09-07
FI85022C (fi) 1992-02-25
KR860005812A (ko) 1986-08-13
NO860273L (no) 1986-07-29
PH22425A (en) 1988-09-12
HU196367B (en) 1988-11-28
ES8706112A1 (es) 1987-06-01
CH670824A5 (es) 1989-07-14
SE9002337D0 (sv) 1990-07-03
US4638061A (en) 1987-01-20
CH670825A5 (es) 1989-07-14
AU588017B2 (en) 1989-09-07
PL257668A1 (en) 1987-03-09
HUT40407A (en) 1986-12-28
CS253740B2 (en) 1987-12-17
AU5246086A (en) 1986-07-31
ES8800897A1 (es) 1987-12-01
FR2576596A1 (fr) 1986-08-01
JPS61176563A (ja) 1986-08-08
CN1014894B (zh) 1991-11-27
BE904121A (fr) 1986-05-15
YU45760B (sh) 1992-07-20
JPH0853404A (ja) 1996-02-27
PL149156B1 (en) 1990-01-31
ES551252A0 (es) 1987-06-01
AR242024A1 (es) 1993-02-26
DD248584A5 (de) 1987-08-12
SE502442C2 (sv) 1995-10-16
SE8600355L (sv) 1986-07-29
PH23093A (en) 1989-04-10
SE9002338D0 (sv) 1990-07-03
FI860247A0 (fi) 1986-01-20
CH667872A5 (fr) 1988-11-15
SE9002338L (sv) 1990-07-03
ES557056A0 (es) 1987-12-01
IE59629B1 (en) 1994-03-09
KR900000675B1 (ko) 1990-02-02
DE3602347A1 (de) 1986-07-31
GB2198133A (en) 1988-06-08
GB8800425D0 (en) 1988-02-10
PT81914A (en) 1986-02-01
YU167087A (en) 1988-04-30
LU86262A1 (fr) 1986-08-04
DD248592A5 (de) 1987-08-12
GB2198133B (en) 1989-01-11
FI860247A (fi) 1986-07-29
CA1283924C (en) 1991-05-07
SE8600355D0 (sv) 1986-01-27
GB2170201A (en) 1986-07-30
PL262317A1 (en) 1987-09-07
RO93483B (ro) 1988-01-01
EG17682A (en) 1990-10-30
SE9002337L (sv) 1990-07-03
ATA20386A (de) 1989-05-15
DK39486D0 (da) 1986-01-27
PH23084A (en) 1989-04-10
NO170014C (no) 1992-09-02
CA1279322C (en) 1991-01-22
NZ214836A (en) 1988-10-28
DK39486A (da) 1986-07-29
IT8619206A0 (it) 1986-01-28
FI85022B (fi) 1991-11-15
IE860205L (en) 1986-07-28
GR860239B (en) 1986-05-28
SE468896B (sv) 1993-04-05
IE930750L (en) 1986-07-28
IT1190604B (it) 1988-02-16
RO93483A (ro) 1987-12-31
JPH0780840B2 (ja) 1995-08-30
PT81914B (pt) 1987-11-30
IL77661A (en) 1989-06-30
CN86100736A (zh) 1986-10-22
YU5886A (en) 1988-02-29
GB2170201B (en) 1989-01-11
NL8600136A (nl) 1986-08-18
FR2576596B1 (fr) 1989-12-15
SE467824B (sv) 1992-09-21
ES8801917A1 (es) 1988-03-01
ZA86302B (en) 1986-08-27
DD241600A5 (de) 1986-12-17
NO170014B (no) 1992-05-25

Similar Documents

Publication Publication Date Title
IT1184551B (it) Complesso di azionamento perfezionato per un innaffiatoio con azionamento a reazione
AU558445B2 (en) 1:-ethoxycarbonyloxyethyl ester of valproic acid
MX3121A (es) Procedimiento para la obtencion del (r)-2-(4-(5-cloro-3-fluorpiridin-2-iloxi)-fenoxi)-propinilester el acido propionico y compuesto obtenido.
ES511816A0 (es) "procedimiento para preparar un acido x-arilalcanoico".
DE3750586D1 (de) Magazin für Filmzuführvorrichtung.
ES557057A0 (es) Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico
ITRM930147A0 (it) Procedimento per la preparazione di sali dell'acido clavulanico. (caso 970-9808)
IT8323898A0 (it) Composizione anti-acne contenent,come composto attivo, un derivato dell'isotiazolo-(5,4b) piridinone-3.
YU148989A (en) Herbicidic compounds, based on benzoic acid derivative
IT1229522B (it) Procedimento per la preparazione di acido n fosfonometiliminodiacetico.
IT1233457B (it) Sali cristallini dell'acido ( 3s (z) ) -2- ((( 1- (2-ammino-4-tiazo- lil)-2-(( 2,2 dimetil-4-osso-1-(solfossi)-3-azetidinil)ammino)-2-osso-etiliden)-ammino)ossi)acetico
ES540091A0 (es) Un procedimiento para preparar el compuesto denominado cl-1565-pt-3
IT1219278B (it) Cartuccia per un nastro di correzione
IT8919666A0 (it) Procedimento per la preparazione di acido 3 alfa 7 beta diidrossicolanico di elevata purezza.
IT8448082A0 (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
IT1148122B (it) Promotore di crescita per bestiame,a base di acido pseudomonico o suoi derivati,formulazioni che lo contengono e suo impiego
ITMI930492A1 (it) Procedimento per preparare acido 1-(25)-metil-3-mercaptopropionil pirrolidina-(2s)-carbossilico.
ES542494A0 (es) Un procedimiento para preparar 1-((3,4-dimetoxifenetil)-ami-no)-3-(m-toliloxi)-2-propanol
ES538473A0 (es) Un procedimiento para preparar el compuesto n-(4-metoxi-2-metilfenil)-3-(5-nitro-2-furanil)-propenamida.
IT8921175A0 (it) Procedimento per la preparazione di acido metossiacetico.
FI853025A0 (fi) Estrar av 0(2,6-diklorfenylamino) fenylaettikssyra och foerfarande foer deras framstaellning.
ES557074A0 (es) Un procedimiento para preparar ester metilico del acido 1-(2,3,5-tri-o-benzoil-beta-d-ribofurasonil)-1,2,4,triazol-3-carboxilico.
AU6268786A (en) A self-release animal veterinary cradle
ES536682A0 (es) Un procedimiento para la preparacion de acido r (2)-4-amino-3-cloro-2-pentenodioico.
IT8223040A0 (it) Nuovo procedimento per lapreparazione di un derivato dell'acido cefalosporanico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102